Analyst Ratings for Chemomab Therapeutics (CMMB)
CMMB Rating Summary
CMMB Price Target Summary
- Highest: $25.00 (Oppenheimer)
- Lowest: $25.00 (Oppenheimer)
- Average: $25.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$25.00 (+1229.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2024 | Maxim Group » Updated 2/20/2025 |
Michael Okunewitch | New Coverage | Buy (N/A) |
7.00 (4.00) |
0.84 (1.88) |
123.81% | Details |
| 5/6/2024 | Oppenheimer » Updated 8/27/2025 |
Jeff Jones | Upgrade | Outperform (Perform) |
25.00 (10.00) |
0.74 (1.88) |
154.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
